IP Library Granted Patent US 10,327,441
Granted Patent B2
US 10,327,441 · App. 15/302,593 · Granted Jun 25, 2019

Modulation of calcium ion homeostasis in harvested transplantable hearts

Inventors: Darren Freed (Edmonton, CA); Christopher White (Edmonton, CA); Larry Hryshko (Winnipeg, CA)
Assignee: TEVOSOL, INC.
A01N1/0226
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,327,441
App. No.
15/302,593
Granted
Jun 25, 2019
Kind
B2
Abstract

An oxygenated cardioplegic composition for immediate reperfusion of a donor heart after its procurement. The composition comprises an adenosine-lidocaine mixture for causing immediate cessation of the heart's systolic function upon contact; a normokalemic concentration of potassium ions; a concentration of Ca 2+ ions selected to maintain the intracellular level of Ca 2+ ions in the harvested heart muscle cells at about 10 −4 mmol/L; and a pH of 6.9. The oxygenated cardioplegic composition is pre-warmed to about 35° C. and then used for immediate reperfusion of a donor heart for at least three minutes after its procurement.

Claims (21)

1. A cardioplegic composition comprising:

400 μmol/L of adenosine;

50 μmol/L of lidocaine;

10.0 mmol/L of glucose;

131.8 mmol/L of NaCl;

5.9 mmol/L of KCl;

14.0 mmol/L of NaHCO 3 ;

1.2 mmol/L of NaH 2 PO 4 ;

0.22 mmol/L of CaCl 2 ;

13.0 mmol/L of MgCl 2 ;

10.0 IU/L of insulin

120.0 mmol/L of D-mannitol;

1.0 mmol/L of pyruvate; and

3.0 mmol/L of reduced glutathione,

wherein the cardioplegic composition has a pH of 6.6 to 6.9.

2. A method comprising:

bathing and reperfusing a donor heart in the cardioplegic composition of claim 1 immediately after procurement of the donor heart, wherein said cardioplegic composition is oxygenated and warmed to about 35° C. prior to use.

3. The cardioplegic composition of claim 1 , wherein the pH is 6.9.

4. The method of claim 2 , wherein the pH of the cardioplegic composition is 6.9.

5. The method of claim 2 , comprising bathing the donor heart in the oxygenated and warmed cardioplegic composition during procurement of the donor heart.

6. The method of claim 5 , wherein the pH of the cardioplegic composition is 6.9.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2023
From: BRIDGE TO LIFE LTD.; TEVOSOL, INC.
To: TRANSMEDICS, INC.
Reel/Frame 064617/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2019
From: FREED, DARREN H
To: TEVOSOL, INC.
Reel/Frame 048994/0647 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2017
From: THE UNIVERSITY OF MANITOBA
To: FREED, DARREN
Reel/Frame 043874/0677 →
Continuity (2)
Provisional Application 61978132 · Apr 10, 2014
Related Publication 20170020127A1 · Jan 26, 2017
Cited By (4)
US 12,185,718 US 12,207,649 US 12,317,888 US 12,396,454